What the research has found so far A 2025 cross-sectional analysis of the FDA Adverse Event Reporting System (FAERS) database, conducted by researchers at Stanford University, identified 182 reported cases of sexual adverse events associated with GLP-1 receptor agonists
BC PharmaCare Limited Coverage - Semaglutide PharmaCare limited-coverage criteria and special-authority request process
The old approach of gaining 40 pounds in an offseason and then dieting away 30 of it makes less sense when better tools exist
Such changes can help protect your heart and body without any real side effects
As an investigational triple-agonist, fully understanding its long-term cardiovascular, gastrointestinal, and pancreatic safety profile is essential before it can transition from a research setting to routine clinical practice. Dr
It is not intended for injection, administration, or any use involving humans or animals